Prelude Therapeutics

PRLD

Börsenwert 287 Mio. $

#	Name	Position	Handelswert	Veränderung Aktien	Anteils- änderung
1	BBA 1 Baker Bros. Advisors New York	61,1 Mio. $	–	–	–
2	2 OrbiMed New York	60,6 Mio. $	–	–	–
3	3 Fidelity Investments Boston, Massachusetts	27,7 Mio. $	-313.709 $	-48.955	-1 %
4	4 UBS AM Chicago, Illinois	14,1 Mio. $	-427.106 $	-66.651	-3 %
5	5 Vanguard Group Malvern, Pennsylvania	5,43 Mio. $	+1.724 $	+269	+0 %
6	6 Massachusetts Financial Services Boston, Massachusetts	3,11 Mio. $	+10.753 $	+1.678	+0,3 %
7	7 BlackRock New York	2,38 Mio. $	-420.250 $	-65.581	-14 %
8	8 T. Rowe Price Associates Baltimore, Maryland	1,82 Mio. $	-80.024 $	-12.488	-4 %
9	9 Candriam SCA Strassen, Luxembourg, Luxembourg	1,09 Mio. $	+347.518 $	+54.231	+43 %
10	10 Bank of America Charlotte, North Carolina	953.257 $	-61.864 $	-9.654	-6 %
11	11 Geode Capital Management Boston, Massachusetts	873.000 $	-53.918 $	-8.414	-5 %
12	12 Renaissance Technologies New York	824.000 $	-44.216 $	-6.900	-5 %
13	13 State of Wisconsin Investment Board Madison, Wisconsin	606.416 $	-55.750 $	-8.700	-8 %
14	14 Susquehanna International Group Bala Cynwyd, Pennsylvania	563.472 $	+510.719 $	+79.699	+586 %
15	15 Barclays London, United Kingdom	548.577 $	+548.892 $	+85.656	+1.657 %
16	16 Morgan Stanley New York	543.291 $	-562.881 $	-87.839	-49 %
17	17 New York Life Investment Management New York	495.280 $	+55.155 $	+8.607	+12 %
18	18 Two Sigma Advisers New York	454.812 $	-219.368 $	-34.233	-31 %
19	19 D.E. Shaw & Co New York	410.750 $	-69.694 $	-10.876	-14 %
20	20 Caxton Associates (New York) New York	395.336 $	-131.616 $	-20.539	-24 %
21	21 Charles Schwab San Francisco, California	384.875 $	+61.960 $	+9.669	+18 %
22	22 Citigroup New York	362.835 $	+330.273 $	+51.540	+604 %
23	23 Two Sigma Investments New York	313.464 $	-344.134 $	-53.703	-51 %
24	24 Millennium Management New York	300.000 $	-68.503 $	-10.690	-18 %
25	25 GSA Capital Partners London, United Kingdom	289.000 $	-40.832 $	-6.372	-12 %

Prelude Therapeutics PRLD Börsenwert 287 Mio. $

Prelude Therapeutics

PRLD

Börsenwert 287 Mio. $